These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials. Thase ME; Haight BR; Richard N; Rockett CB; Mitton M; Modell JG; VanMeter S; Harriett AE; Wang Y J Clin Psychiatry; 2005 Aug; 66(8):974-81. PubMed ID: 16086611 [TBL] [Abstract][Full Text] [Related]
29. Clinical implications of directly switching antidepressants in well-treated depressed patients with treatment-emergent sexual dysfunction: a comparison between vortioxetine and escitalopram. Jacobsen PL; Nomikos GG; Zhong W; Cutler AJ; Affinito J; Clayton A CNS Spectr; 2020 Feb; 25(1):50-63. PubMed ID: 31010445 [TBL] [Abstract][Full Text] [Related]
30. Intermittent amantadine for fluoxetine-induced anorgasmia. Balon R J Sex Marital Ther; 1996; 22(4):290-2. PubMed ID: 9018655 [TBL] [Abstract][Full Text] [Related]
31. Serotonin reuptake inhibitor antidepressants and abnormal bleeding: a review for clinicians and a reconsideration of mechanisms. Andrade C; Sandarsh S; Chethan KB; Nagesh KS J Clin Psychiatry; 2010 Dec; 71(12):1565-75. PubMed ID: 21190637 [TBL] [Abstract][Full Text] [Related]
32. Effect of Vortioxetine vs. Escitalopram on Sexual Functioning in Adults with Well-Treated Major Depressive Disorder Experiencing SSRI-Induced Sexual Dysfunction. Jacobsen PL; Mahableshwarkar AR; Chen Y; Chrones L; Clayton AH J Sex Med; 2015 Oct; 12(10):2036-48. PubMed ID: 26331383 [TBL] [Abstract][Full Text] [Related]
33. Bupropion versus selective serotonin-reuptake inhibitors for treatment of depression. Nieuwstraten CE; Dolovich LR Ann Pharmacother; 2001 Dec; 35(12):1608-13. PubMed ID: 11793630 [TBL] [Abstract][Full Text] [Related]
34. Post-SSRI Sexual Dysfunction: A Literature Review. Bala A; Nguyen HMT; Hellstrom WJG Sex Med Rev; 2018 Jan; 6(1):29-34. PubMed ID: 28778697 [TBL] [Abstract][Full Text] [Related]
35. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder. Foster RH; Goa KL CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224 [TBL] [Abstract][Full Text] [Related]
36. As-needed use of cyproheptadine for treatment of selective serotonin reuptake inhibitor-related female anorgasmia. Javanbakht A J Clin Psychopharmacol; 2015 Feb; 35(1):91-3. PubMed ID: 25502486 [No Abstract] [Full Text] [Related]
37. Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review. Tuccori M; Testi A; Antonioli L; Fornai M; Montagnani S; Ghisu N; Colucci R; Corona T; Blandizzi C; Del Tacca M Clin Ther; 2009 Jun; 31 Pt 1():1426-53. PubMed ID: 19698902 [TBL] [Abstract][Full Text] [Related]
38. Serotonin syndrome induced by a combination of bupropion and SSRIs. Munhoz RP Clin Neuropharmacol; 2004; 27(5):219-22. PubMed ID: 15602102 [TBL] [Abstract][Full Text] [Related]
39. Sustained-release bupropion for selective serotonin reuptake inhibitor-induced sexual dysfunction: a randomized, double-blind, placebo-controlled, parallel-group study. Masand PS; Ashton AK; Gupta S; Frank B Am J Psychiatry; 2001 May; 158(5):805-7. PubMed ID: 11329407 [TBL] [Abstract][Full Text] [Related]
40. Effects of nefazodone on body weight: a pooled analysis of selective serotonin reuptake inhibitor- and imipramine-controlled trials. Sussman N; Ginsberg DL; Bikoff J J Clin Psychiatry; 2001 Apr; 62(4):256-60. PubMed ID: 11379839 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]